Table 3 Risk of treatment failure in six study sites adjusted for age and sex
Characteristic | PCR-corrected cure rate | Hazard ratio 1 (95% CI) | P value |
|---|---|---|---|
Per protocol analysis | Â | Â | Â |
Age group(months) | Â | Â | Â |
6 - 12 | 86.5% (32/37) | 1 | - |
13 - 24 | 91.1% (82/90) | 0.79 (0.25, 2.46) | 0.680 |
25 - 36 | 94.1% (48/51) | 0.46 (0.11, 1.95) | 0.289 |
37 - 59 | 93.7% (74/79) | 0.50 (0.14, 1.76) | 0.283 |
Sex | Â | Â | Â |
Female | 90.5% (114/126) | 1 | Â |
Male | 93.3% (125/134) | 0.71 (0.30, 1.72) | 0.457 |
Study site | Â | Â | Â |
Karonga | 98.0% (49/50) | 1 | - |
Kawale | 97.4% (38/39) | 1.25 (0.08, 20.28) | 0.873 |
Machinga | 90.2% (37/41) | 4.76 (0.52, 43.34) | 0.166 |
Mangochi | 97.4% (41/43) | 2.08 (0.19, 23.16) | 0.550 |
Nkhotakota | 78.1% (32/41) | 10.60 (1.33, 83.94) | 0.025 |
Rumphi | 91.3% (42/46) | 4.33 (0.48, 39.03) | 0.191 |